Log In
Print
BCIQ
Print
Print this Print this
 

lucitanib (AL3810, E-3810)

  Manage Alerts
Collapse Summary General Information
Company Advenchen Laboratories LLC
DescriptionSmall molecule inhibitor of fibroblast growth factor (FGF) receptor 1 (FGFR1) and VEGF
Molecular Target Fibroblast growth factor (FGF) receptor 1 (FGFR1) (CD331) ; Vascular endothelial growth factor (VEGF) receptor
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Cancer (unspecified)
Indication DetailsTreat advanced solid tumors; Treat cancer
Regulatory Designation

Partner

Clovis Oncology Inc.; Servier


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today